NO During CPB in Neonates to Reduce Risk of AKI
Phase 3
40
about 3.5 years
0.00273790700698851–0.0848751172166437
1 site in OH
What this study is about
This trial is testing whether giving nitric oxide during cardiopulmonary bypass (CPB) can help prevent acute kidney injury (AKI) in newborns with congenital heart defects who are undergoing surgery. The goal is to see if this treatment reduces the risk of AKI after surgery.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Nitric Oxide
- 2.Take Oxygen
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
nitric oxide, oxygen
Secondary: Biomarker evidence of AKI - IL-18, Biomarker evidence of AKI - KIM-1, Biomarker evidence of AKI - L-FABP, Biomarker evidence of AKI - NGAL, Biomarker evidence of AKI - urinary nitrite
Cardiology / Heart